| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5B | $4.6B | $6.4B | $7.3B | $7.3B | $6.7B | $6.4B | $6.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.8B | $-0.2B | $1.0B | $1.9B | $2.6B | $1.3B | $1.7B | $1.9B |
| EPS (Basic) | $1.53 | $-0.32 | $0.89 | $1.94 | $2.65 | $1.28 | $1.63 | $1.73 |
| EPS (Diluted) | $1.52 | $-0.32 | $0.88 | $1.93 | $2.63 | $1.27 | $1.62 | $1.71 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $184.4B | $187.2B | $188.3B | $189.8B | $186.3B | $170.3B | $145.0B | $139.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $164.0B | $169.0B | $173.6B | $176.4B | $168.9B | $152.4B | $128.0B | $124.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $20.4B | $18.2B | $14.6B | $13.5B | $17.4B | $18.0B | $17.0B | $15.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $0.7B | $2.9B | $4.5B | $1.2B | $1.7B | $2.9B | $2.5B |
| Investing Cash Flow | $3.2B | $2.5B | $1.4B | $-10.9B | $-15.1B | $-24.7B | $-4.9B | $-2.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-5.9B | $-2.4B | $-4.3B | $6.4B | $13.7B | $23.4B | $2.1B | $-0.0B |